The utility of PROMIS domain measures in dermatologic care
AbstractPatient-reported outcome (PRO) measures play an important role in clinical care. Currently, a broad-spectrum, validated PRO measure suitable for all dermatology patients, as part of clinical care, does not exist. Patient-reported Outcome Measures Information System (PROMIS) measures track specific domain outcomes across all diseases. To assess the relevance and utility of a computer-adaptive health assessment consisting of three PROMIS domains in routine dermatologic care. This retrospective study evaluated a PROMIS health assessment, consisting of three computer-adaptive test domains (pain interference, anxiety, and depression), administered as part of routine clinical care in three dermatology clinics at an academic medical center. The primary objective was to identify clinically significant associations between high PROMIS domain scores (i.e.,t score > 55) and dermatologic disease, as well as change in PROMIS domain scores in response to treatment. The majority of patients who initiated the assessment completed all domains (88.7%). In patients with atopic dermatitis, acne, hidradenitis suppurativa, and psoriasis, high PROMIS scores correlated w ith clinically relevant outcomes, such as severe disease, unsuccessful treatment, uncontrolled disease, and the presence of a mental health condition. PROMIS Pain Interference, anxiety and depression identified patients with severe disease, unsuccessful treatment regimens, poorly-controlled disease, and/or...
Publication date: Available online 30 May 2020Source: The Journal of Foot and Ankle SurgeryAuthor(s): Calvin J. Rushing, Dominick J. Casciato, Joey K. Ead, Steven M. Spinner
Publication date: Available online 30 May 2020Source: European Journal of Obstetrics &Gynecology and Reproductive BiologyAuthor(s): Alessandra Graziottin, Filippo Murina, Dania Gambini, Stefania Taraborrelli, Barbara Gardella, Maria Campo, the VuNet Study Group
Publication date: Available online 30 May 2020Source: Journal of EthnopharmacologyAuthor(s): Thomas Chu, Nan-Lin Wu, Chien-Yu Hsiao, Hsin-Ju Li, Tung-Yi Lin, Cheng-Hung Ku, Chi-Feng Hung
Publication date: Available online 30 May 2020Source: BurnsAuthor(s): Gopal Nambi S, Walid Kamal Abdelbasset
Publication date: Available online 30 May 2020Source: EXPLOREAuthor(s): Bihter Akin, Birsen Karaca Saydam
Publication date: Available online 30 May 2020Source: European Journal of Integrative MedicineAuthor(s): Jingyi Shao, Lingming Zhou, Tianyu Shao, Minrui Ding, Zhuqing Jin
Publication date: Available online 30 May 2020Source: Progress in Neuro-Psychopharmacology and Biological PsychiatryAuthor(s): Gianluca Serafini, Giovanna Canepa, Andrea Aguglia, Andrea Amerio, Davide Bianchi, Magnani, Bernardo Dell'Osso, Maurizio Pompili, Paul B. Fitzgerald, Mario Amore
HIGH blood pressure symptoms can be difficult to spot, but may include severe headaches, chest pain, and finding blood in your urine. You could lower your chances of deadly hypertension symptoms and signs by smelling lavender oil, it's been claimed. Should you check your blood pressure?
Conclusions: Our results indicate that the rs7927894 variant on chromosome 11q13.5 may play a role in the development of atopic dermatitis, but this effect seems to be independent of allergic sensitization and of the well-established filaggrin risk alleles, but may be modulated by gene-gene interactions. PMID: 32467693 [PubMed]
Authors: Oszukowska M, Kozłowska M, Kaszuba A Abstract Introduction: Psoriasis is considered as a risk factor for atherosclerosis and contributes to myocardial infarction, ischemic heart disease and brain stroke. Aim: To estimate the atherogenic potential of psoriasis by analysing antioxidative and prooxidative factors (paraoxonase-1, α-tocopherol, uric acid, homocysteine), compare levels of these parameters between groups of psoriatic patients and healthy individuals as well as to analyse the impact of psoriasis severity and duration on the factors under the study and to define correlation between the m...